In control (CTRL) tumors, CD45+CD11b+F4/80+Ly6G–TAMs (tumor-associated macrophages) made up approximately 12% of all cells; in Slit2-knockdown tumors, this number was just 6%. The gene discussed is SLIT2; the disease is neoplasm.